HIV-1 integrase inhibitors (Ohio State University/Boehringer Ingelheim)

N/A

Report date: 2025/06/11 11:16:52
NME

Base Information

Drug NameHIV-1 integrase inhibitors (Ohio State University/Boehringer Ingelheim)
Drug Alias NamePB-20 (Ohio State University)KF-164KF-171KF-116
ClassificationSmall molecules
Mechanisms of ActionHIV integrase inhibitors
TargetsHIV integrase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesThe Ohio State UniversityBoehringer Ingelheim International Gmbh
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A